The Cannabis Observer
Finance General Global Hemp Legal Marketing Medical Partner content Join
Finance General Global Hemp Legal Marketing Medical Partner content Join
ECS Botanics secures nearly A$12m in dried flower supply contracts
Medical

ECS Botanics secures nearly A$12m in dried flower supply contracts

June 26, 2023
Avecho's CBD Capsule Passes Two-Year Stability Test Ahead of Insomnia Trial
Medical

Avecho's CBD Capsule Passes Two-Year Stability Test Ahead of Insomnia Trial

June 23, 2023
Lawyer campaigns to reunite cannabis deportee with Australian family after decade in UK exile
Legal

Lawyer campaigns to reunite cannabis deportee with Australian family after decade in UK exile

June 22, 2023
Operations Manager Appointment Signals Fresh Growth Push for Cannabis Media Outlet
Finance

Operations Manager Appointment Signals Fresh Growth Push for Cannabis Media Outlet

June 22, 2023
ECS Botanics Reports Record May Revenue as Annual Output Jumps Over 50%
Finance

ECS Botanics Reports Record May Revenue as Annual Output Jumps Over 50%

June 21, 2023
Bioxyne Rolls Out Telehealth Service BLS Clinics in Partnership with InstantScripts
Medical

Bioxyne Rolls Out Telehealth Service BLS Clinics in Partnership with InstantScripts

June 21, 2023
Charlotte's Web Co-Founders Headed to Brisbane for Australian Medicinal Cannabis Symposium
Medical

Charlotte's Web Co-Founders Headed to Brisbane for Australian Medicinal Cannabis Symposium

June 21, 2023
Bod Science Partners with Malaysia's Antah Group to Enter Southeast Asian Medicinal Cannabis Market
Medical

Bod Science Partners with Malaysia's Antah Group to Enter Southeast Asian Medicinal Cannabis Market

June 21, 2023
Legalise Cannabis Party tables simultaneous bills in three states to decriminalise personal use
Legal

Legalise Cannabis Party tables simultaneous bills in three states to decriminalise personal use

June 20, 2023
Balanced THC:CBD Cannabis Oil Shown to Reduce Tourette Syndrome Symptoms in Australian Trial
Medical

Balanced THC:CBD Cannabis Oil Shown to Reduce Tourette Syndrome Symptoms in Australian Trial

June 14, 2023
InhaleRx Doses First Cohort in Pain-Focused Phase One Trial
Medical

InhaleRx Doses First Cohort in Pain-Focused Phase One Trial

June 14, 2023
Avecho Biotechnology Finalises TPM-Enhanced CBD Gummy After Development Push
Medical

Avecho Biotechnology Finalises TPM-Enhanced CBD Gummy After Development Push

June 14, 2023
Ex-ANTG staff launch platform to coach patients through medicinal cannabis treatment
Medical

Ex-ANTG staff launch platform to coach patients through medicinal cannabis treatment

June 14, 2023
Lessons from the First-Ever Cannabis Industry Awards for Australia and New Zealand
Finance

Lessons from the First-Ever Cannabis Industry Awards for Australia and New Zealand

June 13, 2023
Vitura's CanView platform targets two million units by year's end as quarterly sales surge
Medical

Vitura's CanView platform targets two million units by year's end as quarterly sales surge

June 13, 2023
NSW Wellness Centre Hit with $66,600 in TGA Fines Over Medicinal Cannabis Advertising
Marketing

NSW Wellness Centre Hit with $66,600 in TGA Fines Over Medicinal Cannabis Advertising

June 13, 2023
Cann Group's Peter Koetsier appointed to MCIA board
Medical

Cann Group's Peter Koetsier appointed to MCIA board

June 09, 2023
ECS Botanics and Astrid Dispensary Among Top Honourees at the 2023 Cannabis Industry Awards
Finance

ECS Botanics and Astrid Dispensary Among Top Honourees at the 2023 Cannabis Industry Awards

June 09, 2023
Medicinal Cannabis SAS-B Approvals Climb to Second Highest Monthly Total in 2023
Medical

Medicinal Cannabis SAS-B Approvals Climb to Second Highest Monthly Total in 2023

June 05, 2023
MGC Pharma Appoints Ex-AusCann Chief Layton Mills to Board
Medical

MGC Pharma Appoints Ex-AusCann Chief Layton Mills to Board

June 05, 2023
Oz Medicann Group steps out of the shadows with patient-focused pharmaceutical launch
Medical

Oz Medicann Group steps out of the shadows with patient-focused pharmaceutical launch

June 05, 2023
Zelira Therapeutics shares surge after cannabinoid treatment beats Pfizer's Lyrica in pain study
Finance

Zelira Therapeutics shares surge after cannabinoid treatment beats Pfizer's Lyrica in pain study

June 01, 2023
← Newer Page 47 of 75 Older →

Subscribe to The Cannabis Observer newsletter before you leave

Before you go

Get the briefing before you leave

One email a week of cannabis industry coverage. Free. No spam.

  • Weekly roundup of regulation, access schemes, and market moves
  • Filtered for industry professionals
  • Unsubscribe in one click

Join 87 cannabis industry readers already subscribed

Get the free weekly cannabis industry briefing.

© 2026 The Cannabis Observer · Privacy Policy · Terms & Conditions